WHO ICTRP trial
The effect of Trehalose on survival in children
IRCT20221129056657N4 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20221129056657N4 |
|---|---|
| Public title | The effect of Trehalose on survival in children |
| Scientific title | Investigating the effect of Trehalose on survival in children admitted to the intensive care unit |
| Primary sponsor | Mashhad University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | The effect of Trehalose on survival rates in children admitted to the intensive care unit.. |
| Interventions | Intervention 1: Intervention group: Children admitted to the intensive care unit will receive oral Trehalose daily at a dose of 15 gr for 5 days along with a regular diet. Intervention 2: Control group: Children admitted to the intensive… |
| Registration date | Nov 18, 2024 |
| Target size | 170 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: